Amendment: SEC Form SCHEDULE 13D/A filed by Enovix Corporation

Item 3 is hereby supplemented by adding the following: On March 10, 2023 the Charitable Trust purchased 65,134 shares of Common Stock at a weighted-average price of $9.56 per share, as previously reported on a Form 4 filed with the SEC on March 10, 2023. On March 15, 2023 the Charitable Trust purchased 129,111 shares of Common Stock at a weighted-average price of $10.47 per share, as previously reported on a Form 4 filed with the SEC on March 15, 2023. On March 16, 2023 the Charitable Trust purchased 34,899 shares of Common Stock at a weighted-average price of $10.96 per share, as previously reported on a Form 4 filed with the SEC on March 16, 2023. On March 17, 2023 the Charitable Trust purchased 98,700 shares of Common Stock at a weighted-average price of $10.95 per share, as previously reported on a Form 4 filed with the SEC on March 17, 2023. On March 20, 2023 the Charitable Trust purchased 69,557 shares of Common Stock at a weighted-average price of $10.88 per share, as previously reported on a Form 4 filed with the SEC on March 20, 2023. On March 21, 2023 the Charitable Trust purchased 102,599 shares of Common Stock at a weighted-average price of $11.57 per share, as previously reported on a Form 4 filed with the SEC on March 21, 2023. On March 24, 2023, Mr. Rodgers transferred 2,264 shares of Common Stock to the Living Trust for no consideration, as previously reported on a Form 4 filed with the SEC on March 27, 2023. Pursuant to a subscription agreement, entered into on April 17, 2023, the Issuer issued and sold $10.0 million aggregate principal amount of 3.00% Convertible Senior Notes due 2028 ("Convertible Senior Notes") to the Charitable Trust. The Notes are convertible at the option of the Holder into cash, shares of the Common Stock, or a combination of cash and shares of Common Stock, at the Issuer's election, subject to certain adjustments. The Convertible Senior Notes are initially convertible into shares of Common Stock at an initial conversion rate of 64.0800 shares of Common Stock per $1,000 principal amount of Senior Convertible Notes, which is subject to customary anti-dilution adjustment provisions. The Convertible Senior Notes are not convertible within 60 days of July 17, 2025 absent the occurrence of certain conditions relating to the Issuer's stock price. Between May 16-17, 2023, the Living Trust gifted for no consideration an aggregate of 8,000 shares of Common Stock, as previously reported on a Form 4 filed with the SEC on May 17, 2023. On June 5, 2023, the Living Trust gifted for no consideration an aggregate of 2,000 shares of Common Stock, as previously reported on a Form 4 filed with the SEC on June 5, 2023. On June 15, 2023, Mr. Rodgers received 7,336 shares of Common Stock in connection with the settlement of RSUs granted pursuant to the 2021 Plan, as previously reported on a Form 4 filed with the SEC on June 20, 2023. On June 20, 2023, the Living Trust gifted for no consideration an aggregate of 50,000 shares of Common Stock, as previously reported on a Form 4 filed with the SEC on June 22, 2023. On December 22, 2023, the Living Trust donated 36,025 shares of the Common Stock as a charitable contribution to a charitable gift fund for no consideration, as previously reported on a Form 4 filed with the SEC on December 27, 2023. On January 3, 2024, Mr. Rodgers transferred 3,668 shares of Common Stock to the Living Trust for no consideration, as previously reported on a Form 4 filed with the SEC on March 24, 2024. On March 21, 2024, Mr. Rodgers transferred 1,834 shares of Common Stock to the Living Trust for no consideration, as previously reported on a Form 4 filed with the SEC on March 24, 2024. On June 13, 2024, Mr. Rodgers received 15,128 RSUs pursuant to the 2021 Plan, as previously reported on a Form 4 filed with the SEC on June 17, 2024. On June 21, 2024, Mr. Rodgers transferred 1,834 shares of Common Stock to the Living Trust for no consideration, as previously reported on a Form 4 filed with the SEC on June 24, 2024. On September 26, 2024, Mr. Rodgers transferred 3,782 shares of Common Stock to the Living Trust for no consideration, as previously reported on a Form 4 filed with the SEC on September 30, 2024. On December 30, 2024, Mr. Rodgers transferred 3,782 shares of Common Stock to the Living Trust for no consideration, as previously reported on a Form 4 filed with the SEC on December 31, 2024. On April 1, 2025, Mr. Rodgers transferred 3,782 shares of Common Stock to the Living Trust for no consideration, as previously reported on a Form 4 filed with the SEC on April 3, 2025. On June 12, 2024, Mr. Rodgers received 22,543 RSUs pursuant to the 2021 Plan, as previously reported on a Form 4 filed with the SEC on June 13, 2025. On June 16, 2025, Mr. Rodgers transferred 3,782 shares of Common Stock to the Living Trust for no consideration, as previously reported on a Form 4 filed with the SEC on June 17, 2025. On July 21, 2025, the Issuer distributed warrants to purchase Common Stock (the "Dividend Warrants") to the record holders as of July 17, 2025 (the "Record Date") of the Common Stock, at a rate of one Dividend Warrant for each seven shares of Common Stock (rounded down to the nearest whole number), and each holder of the Convertible Senior Notes as of the Record Date at a rate equal to the product of (i) the conversion rate applicable to the Convertible Senior Notes in effect on the Record Date and (ii) the aggregate principal amount (expressed in thousands) of Convertible Senior Notes held by such holder on such date (the "Warrant Distribution"). As a result of the Warrant Distribution, the Living Trust received Dividend Warrants to purchase 2,971,661 shares of Common Stock and the Charitable Trust received Dividend Warrants to purchase 220,113 shares of Common Stock. The Dividend Warrants are exercisable within 60 days of July 21, 2025.

Reflects the aggregate number of warrants to purchase Common Stock distributed on July 21, 2025 to the Issuer's record holders as of July 17, 2025.

See rows (11) and (13) of the cover pages to this Amendment No. 3 for the aggregate number of shares and percentages of the shares beneficially owned by each Reporting Person. The percentages used in this Amendment No. 3 are calculated based upon 193,579,119 shares of Common Stock outstanding as of July 17, 2025 as reported in the Prospectus Supplement filed by the Issuer with the SEC on July 21, 2025.

See rows (7) through (10) of the cover pages to this Amendment No. 3 for the number of shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.

Except as described in this Amendment No. 3, the Reporting Persons have not engaged in any transactions in the Common Stock in the past sixty days.

To the knowledge of each of the Reporting Persons, no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock beneficially owned by the Reporting Persons.

N/A

99.1 Joint Filing Agreement dated February 14, 2023 (incorporated by reference to Exhibit 99.1 to Amendment No. 2 to the Schedule 13D filed with the SEC on February 14, 2023) 99.2 Letter Agreement, dated December 1, 2020, by and among the Issuer and its officers, directors and Initial Stockholders (incorporated by reference to Exjbit 10.1 to the Form 8-K filed by the Issuer with the SEC on December 7, 2020) 99.3 Amendment to Letter Agreement, dated July 14, 2021 by and among the Issuer and its officers, directors and Initial Stockholders (incorporated by reference to Exhibit 10.12 to the Form 8-K filed by the Issuer with the SEC on July 19, 2021) 99.4 Amended and Restated Registration Rights Agreement (incorporated by reference to Exhibit 10.10 to the Form 8-K filed by the Issuer with the SEC on July 19, 2021) 99.5 Warrant Agreement (including Form of Warrant), dated July 21, 2025, between the Company, Computershare Inc., a Delaware corporation, and Computershare Trust Company, N.A., as Warrant Agent (incorporated by reference to Exhibit 4.1 to the Form 8-K filed by the Issuer with the SEC on July 21, 2025)